Biofrontera BFRI
NASDAQ BFRI
$1.49 +0.07 (+4.58%)
As of: Aug 20, 2026 · 3:59 PM EDT

Biofrontera (BFRI) EBITDA Margin Growth (5y) (2025 - 2026)

Biofrontera (BFRI) EBITDA Margin Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Biofrontera 18.87 Mn 14.16 Mn 9.59 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5,861.00
Dec 31, 2025 2,885.00
Sep 30, 2025 -1,776.00